TIZANIDINE VERSUS BACLOFEN IN THE TREATMENT OF SPASTICITY IN MULTIPLE-SCLEROSIS PATIENTS

被引：47

作者：

HOOGSTRATEN, MC

VANDERPLOEG, RJO

VREELING, A

VANDERBURG, W

VANMARLE, S

MINDERHOUD, JM

机构：

来源：

ACTA NEUROLOGICA SCANDINAVICA | 1988年 / 77卷 / 03期

关键词：

D O I：

10.1111/j.1600-0404.1988.tb05899.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：224 / 230

页数：7

共 23 条

[1]

ASHWORTH B, 1964, PRACTITIONER, V192, P540

[2]

CHRZANOWSHI C, 1980, 8TH INT C PHYS MED R, P45

[3]

COWARD DM, 1981, TRIANGLE, P151

[4] ANTISPASTICITY DRUGS - MECHANISMS OF ACTION [J].

DAVIDOFF, RA .

ANNALS OF NEUROLOGY, 1985, 17 (02) :107-116

[5] SELECTIVE DEPRESSION OF SYNAPTIC TRANSMISSION OF SPINAL NEURONS IN THE CAT BY A NEW CENTRALLY ACTING MUSCLE-RELAXANT, 5-CHLORO-4-(2-IMIDAZOLIN-2-YL-AMINO)-2, 1, 3-BENZOTHIODAZOLE (DS103-282) [J].

DAVIES, J .

BRITISH JOURNAL OF PHARMACOLOGY, 1982, 76 (03) :473-481

[6] ELECTROPHYSIOLOGICAL ANALYSIS OF THE MODE OF ACTION OF MUSCLE-RELAXANTS IN SPASTICITY [J].

DELWAIDE, PJ .

ANNALS OF NEUROLOGY, 1985, 17 (01) :90-95

[7] BACLOFEN FOR SPASTICITY IN MULTIPLE-SCLEROSIS - DOUBLE-BLIND CROSSOVER AND 3-YEAR STUDY [J].

FELDMAN, RG ;

KELLYHAYES, M ;

CONOMY, JP ;

FOLEY, JM .

NEUROLOGY, 1978, 28 (11) :1094-1098

[8]

Haber A., 1985, MINIMAL RECORD DISAB

[9] 2-PERIOD CROSSOVER CLINICAL-TRIAL [J].

HILLS, M ;

ARMITAGE, P .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (01) :7-20

[10]

KNAPIK JJ, 1983, ARCH PHYS MED REHAB, V64, P77

← 1 2 3 →